CASP3 and breast carcinoma: Furthermore, treatment with PE, KE, or KEPE after DMBA administration suppressed the proliferation of breast cancer by activation of the apoptotic pathways (as shown by the elevation of caspase-3 activities, DNAF, and caspase-3 expression) and consequently reduced the proportion of transformed mammary cancer cells.